Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    March 2017
  1. SORSCHER S
    Pembrolizumab in Non-Small-Cell Lung Cancer.
    N Engl J Med. 2017;376:996-7.
    PubMed     Text format    



  2. Pembrolizumab in Non-Small-Cell Lung Cancer.
    N Engl J Med. 2017;376:997.
    PubMed     Text format    


    February 2017
  3. MAOZ A, Rennert G, Gruber SB
    T-Cell Transfer Therapy Targeting Mutant KRAS.
    N Engl J Med. 2017;376:e11.
    PubMed     Text format    


  4. RECH AJ, Vonderheide RH
    T-Cell Transfer Therapy Targeting Mutant KRAS.
    N Engl J Med. 2017;376:e11.
    PubMed     Text format    


  5. ROSENBERG SA, Tran E, Robbins PF
    T-Cell Transfer Therapy Targeting Mutant KRAS.
    N Engl J Med. 2017;376:e11.
    PubMed     Text format    


  6. MOK TS, Wu YL, Ahn MJ, Garassino MC, et al
    Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
    N Engl J Med. 2017;376:629-640.
    PubMed     Text format     Abstract available


    December 2016
  7. TRAN E, Robbins PF, Lu YC, Prickett TD, et al
    T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.
    N Engl J Med. 2016;375:2255-2262.
    PubMed     Text format     Abstract available


    October 2016
  8. JOHNSON BE
    Divide and Conquer to Treat Lung Cancer.
    N Engl J Med. 2016.
    PubMed     Text format    


  9. RECK M, Rodriguez-Abreu D, Robinson AG, Hui R, et al
    Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  10. CHOY E, Hornicek FJ, Chen YL, Rosenthal DI, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 26-2016. A 28-Year-Old Woman with Back Pain and a Lesion in the Lumbar Spine.
    N Engl J Med. 2016;375:779-88.
    PubMed     Text format    


    July 2016
  11. POLLARD JW
    Defining Metastatic Cell Latency.
    N Engl J Med. 2016;375:280-2.
    PubMed     Text format    


    June 2016
  12. SEQUIST LV, Soria JC, Camidge DR
    Update to Rociletinib Data with the RECIST Confirmed Response Rate.
    N Engl J Med. 2016;374:2296-7.
    PubMed     Text format    


    May 2016
  13. SWANTON C, Govindan R
    Clinical Implications of Genomic Discoveries in Lung Cancer.
    N Engl J Med. 2016;374:1864-73.
    PubMed     Text format    


  14. BORDI P, Del Re M, Tiseo M
    Crizotinib Resensitization by Compound Mutation.
    N Engl J Med. 2016;374:1790.
    PubMed     Text format    


  15. SHAW AT, Engelman JA
    Crizotinib Resensitization by Compound Mutation.
    N Engl J Med. 2016;374:1790-1.
    PubMed     Text format    


    February 2016
  16. GYAWALI B, Ota A, Ando Y
    Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer.
    N Engl J Med. 2016;374:493.
    PubMed     Text format    


  17. HASEGAWA T, Uno H, Wei LJ
    Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer.
    N Engl J Med. 2016;374:492-3.
    PubMed     Text format    


  18. BORGHAEI H, Brahmer J
    Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer.
    N Engl J Med. 2016;374:493-4.
    PubMed     Text format    


    January 2016
  19. SHAW AT, Friboulet L, Leshchiner I, Gainor JF, et al
    Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.
    N Engl J Med. 2016;374:54-61.
    PubMed     Text format     Abstract available


    October 2015
  20. KHOSROSHAHI A, Digumarthy SR, Gibbons FK, Deshpande V, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 34-2015. A 36-Year-Old Woman with a Lung Mass, Pleural Effusion, and Hip Pain.
    N Engl J Med. 2015;373:1762-72.
    PubMed     Text format    



  21. First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer.
    N Engl J Med. 2015;373:1582.
    PubMed     Text format    



  22. Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer.
    N Engl J Med. 2015;373:1582.
    PubMed     Text format    


    September 2015
  23. BORGHAEI H, Paz-Ares L, Horn L, Spigel DR, et al
    Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    August 2015
  24. HYMAN DM, Puzanov I, Subbiah V, Faris JE, et al
    Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
    N Engl J Med. 2015;373:726-36.
    PubMed     Text format     Abstract available


  25. HUNTER DJ, D'Agostino RB Sr
    Let's Not Put All Our Eggs in One Basket.
    N Engl J Med. 2015;373:691-3.
    PubMed     Text format    


  26. HE Y
    Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer.
    N Engl J Med. 2015;373:578.
    PubMed     Text format    


  27. SEQUIST LV, Rolfe L, Allen AR
    Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer.
    N Engl J Med. 2015;373:578-9.
    PubMed     Text format    


    May 2015
  28. BRAHMER J, Reckamp KL, Baas P, Crino L, et al
    Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  29. KAMDAR MM, Doyle KP, Sequist LV, Rinehart TJ, et al
    Case records of the Massachusetts General Hospital. Case 17-2015. A 44-year-old woman with intractable pain due to metastatic lung cancer.
    N Engl J Med. 2015;372:2137-47.
    PubMed     Text format    


  30. CHIN J, Syrek Jensen T, Ashby L, Hermansen J, et al
    Screening for lung cancer with low-dose CT--translating science into Medicare coverage policy.
    N Engl J Med. 2015;372:2083-5.
    PubMed     Text format    


  31. SILVESTRI GA, Vachani A, Whitney D, Elashoff M, et al
    A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    April 2015
  32. DARDIOTIS E, Ralli S
    Images in clinical medicine. Paraneoplastic neuromyotonia.
    N Engl J Med. 2015;372:e24.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: